TAFA5 and Parkinson disease: Although plasma FAM19A5 levels were found to be higher in PD with the constipation group (2.475 ± 0.479) as compared to PD without the constipation group (2.442 ± 0.547), these differences were statistically insignificant (P = 0.67, t = –0.472).